about
Regulation of iron absorption in hemoglobinopathies.Iron overload: consequences, assessment, and monitoring.The surgeon and the patient with β-thalassaemia intermedia.Current therapy of sickle cell disease.Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Iron overload in thalassemia and sickle cell disease.
@ast
Iron overload in thalassemia and sickle cell disease.
@en
type
label
Iron overload in thalassemia and sickle cell disease.
@ast
Iron overload in thalassemia and sickle cell disease.
@en
prefLabel
Iron overload in thalassemia and sickle cell disease.
@ast
Iron overload in thalassemia and sickle cell disease.
@en
P1476
Iron overload in thalassemia and sickle cell disease
@en
P2093
P356
10.1053/J.SEMINHEMATOL.2005.01.005
P433
P50
P577
2005-04-01T00:00:00Z